These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 7907936

  • 1. Effects of excitatory amino acid transmitters on hypothalamic corticotropin-releasing hormone (CRH) and arginine-vasopressin (AVP) release in vitro: implications in pituitary-adrenal regulation.
    Patchev VK, Karalis K, Chrousos GP.
    Brain Res; 1994 Jan 07; 633(1-2):312-6. PubMed ID: 7907936
    [Abstract] [Full Text] [Related]

  • 2. Central bombesin activates the hypothalamic-pituitary-adrenal axis. Effects on regional levels and release of corticotropin-releasing hormone and arginine-vasopressin.
    Kent P, Anisman H, Merali Z.
    Neuroendocrinology; 2001 Mar 07; 73(3):203-14. PubMed ID: 11307039
    [Abstract] [Full Text] [Related]

  • 3. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
    Costa A, Nappi RE, Polatti F, Poma A, Grossman AB, Nappi G.
    Exp Neurol; 2000 Dec 07; 166(2):376-84. PubMed ID: 11085902
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-1-induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH)--neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis.
    Schmidt ED, Janszen AW, Wouterlood FG, Tilders FJ.
    J Neurosci; 1995 Nov 07; 15(11):7417-26. PubMed ID: 7472494
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of neuroexcitatory amino acids on corticotropin-releasing hormone-41 and vasopressin release from rat hypothalamic explants.
    Costa A, Yasin SA, Hucks D, Forsling ML, Besser GM, Grossman A.
    Endocrinology; 1992 Dec 07; 131(6):2595-602. PubMed ID: 1359961
    [Abstract] [Full Text] [Related]

  • 6. Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons.
    Zelena D, Mergl Z, Makara GB.
    Brain Res; 2005 Jan 21; 1031(2):185-93. PubMed ID: 15649443
    [Abstract] [Full Text] [Related]

  • 7. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG, Patchev V, Vergalla J, Chrousos G, Jones EA.
    J Clin Invest; 1993 May 21; 91(5):1903-8. PubMed ID: 8387536
    [Abstract] [Full Text] [Related]

  • 8. The hypothalamic melanocortin system stimulates the hypothalamo-pituitary-adrenal axis in vitro and in vivo in male rats.
    Dhillo WS, Small CJ, Seal LJ, Kim MS, Stanley SA, Murphy KG, Ghatei MA, Bloom SR.
    Neuroendocrinology; 2002 Apr 21; 75(4):209-16. PubMed ID: 11979051
    [Abstract] [Full Text] [Related]

  • 9. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB, Fairhall KM, Robinson IC.
    Endocrinology; 1997 Apr 21; 138(4):1585-91. PubMed ID: 9075719
    [Abstract] [Full Text] [Related]

  • 10. Effect of excitatory amino acid on the hypothalamo-pituitary-adrenal axis in the rat during the stress-hyporesponsive period.
    Chautard T, Boudouresque F, Guillaume V, Oliver C.
    Neuroendocrinology; 1993 Jan 21; 57(1):70-8. PubMed ID: 8097578
    [Abstract] [Full Text] [Related]

  • 11. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum.
    Mastorakos G, Ilias I.
    Ann N Y Acad Sci; 2003 Nov 21; 997():136-49. PubMed ID: 14644820
    [Abstract] [Full Text] [Related]

  • 12. Androgens alter corticotropin releasing hormone and arginine vasopressin mRNA within forebrain sites known to regulate activity in the hypothalamic-pituitary-adrenal axis.
    Viau V, Soriano L, Dallman MF.
    J Neuroendocrinol; 2001 May 21; 13(5):442-52. PubMed ID: 11328455
    [Abstract] [Full Text] [Related]

  • 13. The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.
    Korbonits M, Little JA, Forsling ML, Tringali G, Costa A, Navarra P, Trainer PJ, Grossman AB.
    J Neuroendocrinol; 1999 Jul 21; 11(7):521-8. PubMed ID: 10444309
    [Abstract] [Full Text] [Related]

  • 14. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M, Cover PO, Poyser RH, Buckingham JC.
    Br J Pharmacol; 1997 Jun 21; 121(3):459-68. PubMed ID: 9179387
    [Abstract] [Full Text] [Related]

  • 15. Arginine-vasopressin stimulates CRH and ACTH release by rat adrenal medulla, acting via the V1 receptor subtype and a protein kinase C-dependent pathway.
    Mazzocchi G, Malendowicz LK, Rebuffat P, Tortorella C, Nussdorfer GG.
    Peptides; 1997 Jun 21; 18(2):191-5. PubMed ID: 9149290
    [Abstract] [Full Text] [Related]

  • 16. Effect of endotoxin on the hypothalamic-pituitary-adrenal axis in sheep.
    Dadoun F, Guillaume V, Sauze N, Farisse J, Velut JG, Orsoni JC, Gaillard R, Oliver C.
    Eur J Endocrinol; 1998 Feb 21; 138(2):193-7. PubMed ID: 9506866
    [Abstract] [Full Text] [Related]

  • 17. Release of hypothalamic corticotropin-releasing hormone and arginine-vasopressin by interleukin 1 beta and alpha MSH: studies in rats with different susceptibility to inflammatory disease.
    Zelazowski P, Patchev VK, Zelazowska EB, Chrousos GP, Gold PW, Sternberg EM.
    Brain Res; 1993 Dec 17; 631(1):22-6. PubMed ID: 8298992
    [Abstract] [Full Text] [Related]

  • 18. Impact of repeated stressor exposure on the release of corticotropin-releasing hormone, arginine-vasopressin and bombesin-like peptides at the anterior pituitary.
    Merali Z, Hayley S, Kent P, McIntosh J, Bédard T, Anisman H.
    Behav Brain Res; 2009 Mar 02; 198(1):105-12. PubMed ID: 19014976
    [Abstract] [Full Text] [Related]

  • 19. Lactic acid does not directly activate hypothalamic-pituitary corticotroph function.
    Petrides JS, Deuster PA, Mueller GP.
    Proc Soc Exp Biol Med; 1999 Feb 02; 220(2):100-5. PubMed ID: 9933504
    [Abstract] [Full Text] [Related]

  • 20. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R.
    J Neuroendocrinol; 1996 Aug 02; 8(8):579-85. PubMed ID: 8866244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.